Press release
North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR
IntroductionBiliary and pancreatic disorders such as gallstones, strictures, bile duct cancers, and pancreatitis represent significant healthcare challenges in North America. Diagnostic and therapeutic interventions like Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) have become indispensable in managing these conditions.
Both procedures require advanced devices - including endoscopes, catheters, guidewires, stents, and balloon dilators - designed for precision and minimally invasive treatment. Rising prevalence of gastrointestinal (GI) cancers, an aging population, and technological advancements in imaging and therapeutic tools are driving the adoption of ERCP and PTC devices. As hospitals and specialized GI centers expand their capabilities, the North America ERCP and PTC Devices Market is set for steady growth through 2034.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72322
Market Overview
According to Exactitude Consultancy, the North America ERCP and PTC Devices Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.6 billion by 2034, growing at a CAGR of 8.1% during the forecast period.
Key Highlights
• Rising incidence of pancreatic and biliary diseases, particularly in the U.S.
• Increasing demand for minimally invasive diagnostic and therapeutic procedures.
• Growing hospital investments in endoscopy units and advanced imaging technologies.
• Favorable reimbursement policies and patient preference for shorter recovery times.
• Barriers include high costs of advanced devices and limited expertise in smaller hospitals.
Leading Players include Boston Scientific, Olympus Corporation, Cook Medical, Medtronic, CONMED Corporation, and Teleflex.
Segmentation Analysis
By Product
• Endoscopes (Duodenoscopes, Cholangiopancreatoscopes)
• Catheters & Cannulas
• Guidewires
• Balloon Dilators
• Stents (Plastic & Metal)
• Sphincterotomes
• Accessories (Forceps, Baskets, Retrieval Devices)
By Platform
• Hospitals
• Ambulatory Surgical Centers
• Specialty Gastroenterology Clinics
By Technology
• Conventional ERCP Devices
• Digital ERCP Imaging Devices
• Fluoroscopy-Guided PTC Devices
• Ultrasound-Assisted PTC Devices
By End-Use
• Diagnostic Applications
• Therapeutic Applications
By Application
• Gallstones & Bile Duct Disorders
• Pancreatic Diseases
• Malignant Strictures & Biliary Cancers
• Post-Transplant Complications
• Others
Segmentation Summary
Endoscopes and stents represent the largest product categories due to their critical role in ERCP and PTC procedures. While diagnostic applications dominate currently, therapeutic applications such as stent placements and bile duct dilations are expected to grow faster. Hospitals remain the primary platform, but ambulatory surgical centers are gaining traction due to their ability to deliver cost-effective and specialized procedures.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72322/north-america-ercp-and-ptc-devices-market
Regional Analysis
United States
• Largest market in North America, accounting for over 70% of regional revenue.
• High incidence of pancreatic cancer and gallstone-related diseases.
• Significant adoption of digital imaging ERCP and advanced stent technologies.
• Strong reimbursement frameworks and concentration of specialized GI centers.
Canada
• Growing demand for minimally invasive diagnostic solutions.
• Government initiatives to improve access to GI cancer screening and treatment.
• Limited but expanding adoption of advanced therapeutic devices in urban hospitals.
Mexico
• Rising prevalence of gallbladder and bile duct diseases.
• Market driven by medical tourism and increasing availability of specialized endoscopy centers.
• Affordability remains a key challenge, but private healthcare facilities are expanding device adoption.
Regional Summary
The U.S. dominates the market with robust infrastructure and high patient volumes, while Canada and Mexico are expanding steadily, supported by rising healthcare investments and adoption of advanced endoscopic techniques.
Market Dynamics
Growth Drivers
1. Rising burden of GI cancers and biliary diseases - Increasing cases of pancreatic and bile duct cancers are driving demand for ERCP and PTC procedures.
2. Shift toward minimally invasive solutions - Patient preference for procedures with shorter recovery times boosts adoption.
3. Technological advancements - Digital imaging, advanced guidewires, and self-expanding stents improve outcomes.
4. Reimbursement coverage - U.S. insurance frameworks support ERCP and PTC procedures, encouraging utilization.
Challenges
• High costs of advanced devices, particularly digital ERCP systems.
• Limited expertise and availability of skilled gastroenterologists in smaller centers.
• Risk of complications, including pancreatitis post-ERCP.
Latest Trends
• Adoption of AI-assisted imaging and navigation systems for enhanced diagnostic accuracy.
• Development of biodegradable stents to reduce repeat interventions.
• Growing role of robotics in endoscopy, improving precision and control.
• Increasing use of hybrid procedures combining ERCP and PTC for complex cases.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72322
Competitor Analysis
Major Players in North America
• Boston Scientific Corporation
• Olympus Corporation
• Cook Medical
• Medtronic plc
• CONMED Corporation
• Teleflex Incorporated
• Pentax Medical (HOYA Group)
• Becton, Dickinson and Company (BD)
• Merit Medical Systems
• Advanced Sterilization Products (ASP)
Competitive Landscape Summary
Boston Scientific and Olympus dominate the ERCP device segment with strong endoscope and stent portfolios. Cook Medical and Medtronic are leaders in guidewires, catheters, and specialty devices. Emerging players are focusing on cost-effective and innovative stent technologies. Partnerships with hospitals and expansion into Mexico's medical tourism sector are becoming key strategies to capture growth.
Conclusion
The North America ERCP and PTC Devices Market is projected to grow from USD 1.2 billion in 2024 to USD 2.6 billion by 2034, at a CAGR of 8.1%. Rising disease prevalence, growing adoption of minimally invasive solutions, and technological advancements in imaging and therapeutic devices are shaping market expansion.
Key Takeaways
• Endoscopes and stents remain the core device categories.
• The U.S. dominates in adoption, while Canada and Mexico show steady growth.
• Technological innovation - digital imaging, AI integration, and biodegradable stents - will drive the next wave of advancements.
• Competitive success will rely on expanding access, affordability, and specialized GI expertise.
This report is also available in the following languages : Japanese (北米のERCPおよびPTCデバイス市場), Korean (북미 ERCP 및 PTC 장치 시장), Chinese (北美 ERCP 和 PTC 设备市场), French (Marché nord-américain des dispositifs ERCP et PTC), German (Nordamerikanischer Markt für ERCP- und PTC-Geräte), and Italian (Mercato dei dispositivi ERCP e PTC del Nord America), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72322
Our More Reports:
Optic Atropy Market
https://exactitudeconsultancy.com/reports/72268/optic-atropy-market
Open-Angle Glaucoma Market
https://exactitudeconsultancy.com/reports/72266/open-angle-glaucoma-market
Neovascular Age-related Macular Degeneration Market
https://exactitudeconsultancy.com/reports/72264/neovascular-age-related-macular-degeneration-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America ERCP and PTC Devices Market Expected to Grow at 8.1% CAGR here
News-ID: 4195924 • Views: …
More Releases from Exactitude Consultancy

Uveitis Market Forecasted to Reach USD 4.1 Billion by 2034
Uveitis is an inflammatory eye disease that affects the uvea, the middle layer of the eye. It can lead to symptoms such as pain, redness, blurred vision, and sensitivity to light, and can result in retinal damage, cataracts, glaucoma, and permanent vision loss if left untreated. Uveitis can be caused by a variety of factors, including autoimmune diseases (e.g., rheumatoid arthritis, sarcoidosis), infections, and trauma, and may affect either one…

North America Gastric Bands and Balloons Market Projected to Grow at 7.5% CAGR
Introduction
Obesity has become a critical public health challenge in North America, with rising prevalence rates leading to increased risks of diabetes, cardiovascular disease, and other chronic conditions. As healthcare systems focus on preventive care and weight management, demand for bariatric interventions has surged. Among the available options, gastric bands and balloons have gained popularity as effective, minimally invasive treatments for obesity.
These devices provide an alternative to traditional bariatric surgery by…

Glaucoma Market Forecasted to Reach USD 6.9 Billion by 2034
Glaucoma is a group of eye diseases characterized by optic nerve damage, often due to increased intraocular pressure (IOP). It is a leading cause of irreversible blindness, particularly among elderly populations. The two most common types are primary open-angle glaucoma (POAG) and angle-closure glaucoma, with POAG accounting for over 70% of glaucoma cases.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72297
With the growing burden of aging populations, rising prevalence…

Retinitis Pigmentosa Market Forecasted to Reach USD 4.5 Billion by 2034
Retinitis pigmentosa (RP) is a genetically heterogeneous group of inherited retinal diseases that cause progressive degeneration of the retina, primarily affecting the photoreceptor cells. It leads to progressive vision loss, starting with night blindness and peripheral vision loss and eventually advancing to central vision loss. RP is a leading cause of blindness in young adults, with a global prevalence of 1 in 4,000 individuals.
Download Full PDF Sample Copy of Market…
More Releases for ERCP
ERCP Device Market Size And Global Industry Forecast 2034
"The Endoscopic Retrograde Cholangiopancreatography (ERCP) device market is currently valued at approximately $1.2 billion in 2024. The market is projected to grow significantly, reaching an estimated $2.4 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034."
Exactitude Consultancy., Ltd. released a research report titled "ERCP Device Market". This report covers the global ERCP Device market sales, sales volume, price,…
Endoscopic Retrograde Cholangiopancreatography/ERCP Market worth $2.0 billion by …
North America accounted for the largest share of the ERCP market. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.
According to the new market research report "Endoscopic Retrograde Cholangiopancreatography/ERCP Market [https://www.marketsandmarkets.com/Market-Reports/endoscopic-retrograde-cholangiopancreatography-ercp-market-170242954.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=ercpmarket] by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy),…
ERCP Catheter Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growt …
ERCP Catheter Market
The global ERCP Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for ERCP Catheter is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ERCP Catheter is…
Asia-Pacific ERCP Devices Market: Navigating Growth and Innovation
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market report provides details of market share, new developments, and impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief. Our team will help you create a…
Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Size to Cross $1,87 …
𝐀𝐜𝐜𝐨𝐫𝐝𝐢𝐧𝐠 𝐭𝐨 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐄𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐢𝐜 𝐑𝐞𝐭𝐫𝐨𝐠𝐫𝐚𝐝𝐞 𝐂𝐡𝐨𝐥𝐚𝐧𝐠𝐢𝐨𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐭𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞𝐝 $1.21 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2019, 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐞 $1.87 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027, 𝐰𝐢𝐭𝐧𝐞𝐬𝐬𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 5.6% 𝐟𝐫𝐨𝐦 2019 𝐭𝐨 2027. 𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐨𝐟𝐟𝐞𝐫𝐬 𝐚𝐧 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐫𝐞𝐧𝐝𝐬, 𝐤𝐞𝐲 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬, 𝐭𝐨𝐩 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐩𝐨𝐜𝐤𝐞𝐭𝐬, 𝐯𝐚𝐥𝐮𝐞 𝐜𝐡𝐚𝐢𝐧, 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞, 𝐚𝐧𝐝 𝐫𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨.
Endoscopy is a clinical process to observe body tissue or internal…
Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Bilia …
"The Report Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures Outlook to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
GlobalDatas new report, "Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures Outlook to 2023", provides key procedures data on the Spain Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures. The report provides procedure volumes within market…